B Cells Producing Pathogenic Autoantibodies

Molecular Biology of B Cells

Volumn , Issue , 2004, Pages 381-401

  Bona, Constantin A ^a   Stevenson, Freda K ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84941653247     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012053641-2/50026-5     Document Type: Chapter

References (202)

1. Ehrlich P. On immunity with special reference to cell life. Proc R Soc Lond 1900, 66:424-428.
2. Burnet F.M. The clonal theory of acquired immunity 1959, Cambridge University Press, London.
3. Nemazee D.A., Burk K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989, 33:562-566.
4. Goodnow C.C., Crosby J., Jorgensen H., Brink R.A., Basten A. Induction of self tolerance in mature peripheral B lymphocytes. Nature 1989, 342:385-391.
5. Brombacher F., Kohler G., Eibel H. B cell tolerance in mice transgenic for anti-CD8 immunoglobulin m chain. J Exp Med 1991, 174:1335-1346.
6. Tiegs S.L., Ussel D.M., Nemazee D. Receptor editing in self-reactive bone marrow B cells. J Exp Med 1993, 177:1009-1020.
7. Lortan J.E., Roobottom-Oldfields C.A., McLeanan I.C. Newly produced virgin B cells migrate to secondary lymph nodes but their capacity to enter follicles is restricted. Eur J Immunol 1987, 17:1311-1316.
8. Kaushik A.K., Bona C.A. Genetic origin of murine autoantibodies. The molecular pathology of autoimmune diseases 2002, 53-68. Taylor and Francis, New York, London. A. Theophilopoulos, C. Bona (Eds.).
9. Donath J., Landsteiner K. Ueber paroxymale hamoglobinurie. Munch med Wochenschr 1904, 51:1590-1593.
10. Ehrlich P. Ueber paroxymale haemoglobinurie. Deutsch Med Wochenschr 1905, 7:224-225.
11. Diamond B., Scharff M.D. Somatic mutation of the T-15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci USA 1984, 81:5841-5844.
12. Kabat E.A., Wolf A., Bezer A.E. Rapid production of acute disseminated encephalomyelitis in Rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. J Exp Med 1947, 85:117-130.
13. Freund J., Lipton M.M., Thompson G.E. Aspermatogenesis in guinea pigs induced by testicular tissue and adjuvants. J Exp Med 1953, 97:711-726.
14. Rose N.R., Witebsky E. Changes in thyroid glands of rabbits following immunization with rabbit thyroid extracts. J Immunol 1956, 76:417-427.
15. Nossal G.V.J. Bone marrow pre-B cells and the clonal anergy theory of immunological tolerance. Int Rev Immunol 1987, 2:231-338.
16. Hartley S.B., Crosbie J., Brink R., Kantor A.B., Basten A., Goodnow C.C. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-associated antigen. Nature 1991, 353:765-769.
17. Gay D., Saunders T., Camper S., Weigert M. Receptor editing: An approach by autoreactive B cells to escape tolerance. J Exp Med 1993, 177:999-1008.
18. Casellas R., Shih T.-A.Y., Kleinrwietfeld M., Rakonjac J., Nemazee D., Rajewsky K., Nussenzweig M.C. Contribution of receptor editing to the antibody repertoire. Science 2001, 291:1541-1544.
19. Chu J.-L., Drappa J., Parnassa A., Elkon K.B. The defect in Fas mRNA expression in MTL/lpr mice is associated with insertion of the retrotransposom, ETN. J Exp Med 1993, 178:723-730.
20. Hahne M., Peitsch M.C., Irmler M., Schroner M., Lowin B., Rousseau M., Bron C., Renno T., French L., Tschopp J. Characterization of non-functional Fas ligand in gld mice. Int Immunol 1995, 7:1381-1386.
21. Izui S., Merino R., Fossati L., Iwamoto M. The role of Yaa gene in lupus syndrome. Int Rev Immunol 1994, 11:211-230.
22. Siracusa L.D., McGrath R., Ma Q., Moskow J.J., Manne J., Christner P.J., Buchberg A.M., Jimenez S.A. A tandem duplication within the fibrillin 1 gene is associated with tight skin mutation. Genomic Res 1996, 6:300-313.
23. Kasturi K.N., Hatakeyama A., Murai C., Gordon R.M., Phelps R.G., Bona C.A. B-cell deficiency does not abrogate development of cutaneous hyperplasia in mice inheriting the defective fibrillin-1 gene. J Autoiimmunity 1997, 10:505-517.
24. Smoyer W.E., Kelly C.J. Inherited interstitial nephritis in kd/kd mice. Int Rev Immunol 1994, 11:245-253.
25. Bignon J.S., Siminovitch K. Identification of PTP1C mutation as defect in motheaten viable mice. Clin Immunol Immunopathol 1994, 73:168-179.
26. Dighiero G., Lymberi P., Mazie J., Rousye S., Avreamas S. Murine hybridomas secreting natural antibodies reacting with self epitopes. J Immunol 1983, 131:2267-2272.
27. Kabat E.A., Nickerson K.G., Liao J., Grossbard L., Osserman E.F., Gliekman E., Chess L., Robbins J.B., Scheneerson R., Yanag Y. A human monoclonal macroglobulin with specificity for α (2-8) linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denaturated DNA. J Exp Med 1986, 164:642-654.
28. Dighiero G., Lymberi P., Holmberg D., Lundquist I., Couthino A., Avreameas S. High frequency of natural autoantibodies in normal newborn mice. J Immunol 1985, 134:765-771.
29. Harindranath N., Ikematsu H., Notkins A.L., Casali P. Structure of VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherchia coli betagalactosidase. Int Immunol 1993, 5:1523-1533.
30. Casali P., Prabhakar S., Notkins A.L. Characterization of multireactive autoantibodies and identification of LEU-1 B lymphocytes as cells making antibodies binding multiple self and exogenous molecules. Int Rev Immunol 1988, 3:17-47.
31. Hayakawa K., Hardy R.R., Honda M., Herzenberg L.A., Steinberg A.D., Herzenberg L.A. Ly-1 B cells: Functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA 1984, 81:2494-2498.
32. Lundkvist I., Couthino A., Varela F., Holmberg D. Evidence for a functional idiotypic network among natural antibodies in normal mice. Proc Natl Acad Sci USA 1989, 86:5074-5078.
33. Grabar P. Autoantibodies and physiological role of immunoglobulins. Immunol Today 1983, 4:337-340.
34. Schwartz R.S. Polyvalent anti-DNA antibodies: Immunochemical and biological significance. Int Rev Immunol 1998, 3:97-117.
35. Davies T., Kendler D.L., Martin A. Immunological mechanisms in Graves' disease. The molecular pathology of autoimmune diseases 2002, 649-684. Taylor and Francis, New York, London. A. Theophilopoulos, C. Bona (Eds.).
36. Mariotti S., Caturegli P., Piccolo P., Barbesino G., Pichera A. Antithyroglobulin antibodies in thyroid diseases. J Clin Endocrinol Metab 1990, 71:661-669.
37. Henry M., Zanelli E., Piechaczyk M., Pau B., Malthiery Y. A major human thyroglobulin epitope defined with monoclonal antibodies is mainly recognized by human autoantibodies. Eur J Immunol 1992, 22:315-319.
38. Witebsky E., Rose N.R., Terplan K., Paine J.R., Egan R.W. Chronic thyroiditis and autoimmunization. JAMA 1957, 164:1439-1447.
39. Bona C.A. Postulates defining pathogenic autoantibodies and T cells. Autoimmunity 1991, 10:162-172.
40. Rose N.R., Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993, 14:426.
41. Rokeach L.A., Hasbley J.A., Hoch S.O. Molecular cloning of a cDNA encoding human SM-D autoantigen. Proc Natl Acad Sci USA 1988, 85:4832-4836.
42. Boutler J., Evans K., Goldman D., Martin G., Treco D., Heineman S., Patrick J. Isolation of a cDNA clone coding for a possible nicotinic acetylcholine receptor subunit. Nature 1986, 130:368-380.
43. Reeves W.H., Sthoeger Z.M. Molecular cloning of a cDNA encoding the p70 (Ku) lupus autoantigen. J Biol Chem 1989, 264:5947-5952.
44. Tsui F.W.L., Siminovitch L. Structural analysis of the 5' region of gene for hamster hystidyl-tRNA synthetase. Gene 1987, 61:349-361.
45. Netter H.J., Guldner H.H., Szosteki C., Lakomek H.-J., Will H. A recombinant autoantigen derived from the human (U1) small nuclear RNP-specific 68-kd protein. Arthritis Rheum 1988, 31:616-622.
46. Patrick J., Lindstrom J.M. Autoimmune response to acetylcholine receptor. Science 1973, 180:871-872.
47. Amagai M., Tsunoda K., Suzuki H., Nishifuji K., Koyasu S., Nishikawa T. Use of autoantigen-knock out mice in developing disease model for pemphigus. J Clin Invest 2000, 105:625-631.
48. Steblay R.W. Glomerulonephritis induced in sheep by injection with glomerular basal membrane in Freund's complete adjuvant. J Exp Med 1962, 116:253.
49. Namba T., Brown S.B., Grob D. Neonatal myasthenia gravis: Report of two cases and review of the literature. Pediatrics 1970, 45:488-496.
50. Brenner T., Shahin R., Steiner I., Abramsky O. Presence of anti-acethylcholine receptor autoantibodies in human milk: Possible correlation with neonatal myasthenia gravis. Autoimmunity 1992, 12:3150-3160.
51. Lefvert A. Anti-idiotype antibodies in myasthenia gravis. Biological applications of anti-idiotypes 1988, 69-81. CRC Press, Boca Raton, FL. C. Bona (Ed.).
52. Shields C.L., Nelson L.B., Carpenter G.C., Shields J.A. Neonatal Graves' disease. Br J Ophtalmol 1988, 72:424-427.
53. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999, 9:727-733.
54. Smith C., Thomsett M., Choong C., Rodda C., McIntire H.D., Cotterill A.M. Congenital thyrotoxicosis in premature infants. Clin Endocrinol 2001, 54:372-376.
55. Kohn L.D., Sizuki K., Hoffman W.H., Tombaccini D., Marcocci C., Shimojo N., Watanabe Y., Asmin N., Cho B.Y., Kohno Y., Hirai A., Tahara K. Characterization of monoclonal thyroid stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. J Clin Endocrinol Metabol 1997, 82:3998-4009.
56. Forst P., Lifshitz F., Puglise M., Klein I. Neonatal thyroid disease: Differential expression in three successive offspring. J Clin Endocrinol Metab 1988, 66:645-647.
57. Eronen M., Siren M.K., Ekblad H., Tikanoja T., Julkunen H., Paavllanen T. Short and long-term outcome of children with congenital heart diagnosed as newborn. Pediatrics 2000, 106:86-91.
58. Miyagawa S., Fukamoto T., Hashimoto K., Hachiya T., Yoshioka A., Shirai T. Maternal autoimmune response to recombinant Ro/SSA and LA/SSB proteins in Japanese neonatal lupus erythematosus. Autoimmunity 1995, 21:277-282.
59. Avalos-Diaz E., Olague-Marchan M., Lopez-Swiderski A., Herrera-Esoarza R., Diaz L.A. Transplacental passage of maternal pemphigus foliaceus autoantibodies induces neonatal pemphigus. J Am Acad Deramatol 2000, 43:1130-1134.
60. Harrington W.J., Minnich V., Hollingsworth J.W., Moore C.V. Demonstration of circulating factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951, 38:1-10.
61. Anhalt G.J., Labib R.S., Voorhes J.J., Beals T.F., Diaz L.A. Induction of pemphigus in neonatal mice by transfer of IgG from patients with disease. N Engl J Med 1982, 306:1189-11906.
62. Richman D.P., Gomez C.M., Berman P.W., Burres S.A., Fitch F.W., Amason B.G. Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia. Nature 1980, 286:728-739.
63. Loutari H., Kokla H.B., Tzartos S.J. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor. Eur J Immunol 1992, 22:2499.
64. Budhai L., Oh K., Davinson A. An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with lupus erythematosus. J Clin Invest 1996, 98:1585-1593.
65. Lerner R.A., Glassock R.J., Dixon F.J. The role of anti-glomelular basement antibody in the pathogenesis of glomerulonephritis. J Exp Med 1967, 126:989-1004.
66. Foidart J.-M., Abe S., Martin G., Zizic T.M., Barnett E.V., Lawley T.J., Katz S.I. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 1978, 299:1203-1297.
67. Okamoto M., Murakimi M., Shimizu A., Ozaki S., Tsubata T., Kumagai S., Honjo T. A transgenic model for autoimmune hemolytic anemia. J Exp Med 1992, 175:71-79.
68. Erikson J., Radic M.Z., Camper S.A., Hardy R.R., Carmak C., Weigert M. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 1991, 349:331-334.
69. Tsao B.P., Ohnishi K., Cheroutre B., Mitchell M., Titell P., Mixter P., Kronenberg M., Hahn B.H. Failed self tolerance and autoimmunity in IgG anti-DNA transgenic mice. J Immunol 1992, 149:350-361.
70. Ohnishi K., Ebling F.M., Mitchel B., Singh R.R., Hahn B.H., Tsao B.P. Comparison of pathogenic and non-pathogenic murine antibodies to DNA antigen binding and structural characteristics. Int Immunol 1994, 6:817-830.
71. Dumas G., Pritsch O., Pereira A., Gallart T., Dighiero G. A murine model of human cold agglutinin diseases. Br J Haematol 1997, 98:589-596.
72. Chevillard C., Ozaki J., Herrig C.D., Riblet R. A three-megabase yeast artificial chromosome spanning the C57BL mouse Igh locus. J Immunol 2002, 168:5659-5666.
73. Livant D., Blatt C., Hood L. One heavy chain variable region gene segment subfamily in the Balb/c mouse contains 500-1000 or more members. Cell 1986, 47:461-470.
74. Schable K.F., Thiebe R., Bensch A., Brensig-Kuppers J., Heim V., Kirshbaum T., Lamm R., Ohnrich M., Pourrajabi S., Roschenthaler F., Schwendinger J., Wichelhaus D., Zocher I., Zachau H.G. Characteristics of the immunoglobulin Vk genes, pseudogenes, relics and orphons in the mouse. Eur J Immunol 1999, 29:2082-2086.
75. Pricop L., Brumeanu T., Elahi E., Moran T., Wang B.S., Troustine M., Huszar D., Alt F., Bona C. Antibody response elicited by T-dependent and T independent antigens in gene targeted K-deficient mice. Int Immunol 1994, 6:1839-1847.
76. Hatakeyama A., Pricop L., Kasturi K.N., Bona C.A. Study of self-reactive antibodies in kappa-light chain deficient mice. Autoimmunity 1995, 20:113-120.
77. Reininger L., Ollier P., Poncet P., Kaushik A., Jaton J.-C. Novel V genes encode virtually identical variable regions of six monoclonal anti-bromelain-treated red blood cell autoantibodies. J Immunol 1987, 138:316-323.
78. Hardy R.H., Carmak C.E., Shinton S.A., Riblet R.J., Hayakama K. A single Vh gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. J Immunol 1989, 142:3643-3651.
79. Carmack C.E., Shinton S.A., Hayakawa K., Hardy R.R. Rearrangement and selection of VH11 in the Ly-1B cell lineage. J Exp Med 1990, 172:371-374.
80. Painter C.J., Monestier M., Chew A., Bona-Dimitriu A., Kasturi K., Bailey C., Scott V., Sidman C.L., Bona C.A. Specificities and V genes encoding monoclonal autoantibodies from viable motheaten mice. J Exp Med 1988, 167:1137-1153.
81. Kasturi K.N., Mayer R., Bona C.A., Scott V.E., Sidman C.L. Germline V genes encode viable motheaten mouse autoantibodies against thymocytes and red blood cells. J Immunol 1990, 145:2304-2311.
82. Holmdahl R., Bailey C., Enader I., Mayer R., Klareskog L., Moran T., Bona C. Origin of autoreactive anti-type II collagen response. J Immunol 1989, 142:1881-1886.
83. Kaushick A., Schultze D.H., Bonilla F.A., Bona C., Kelsoe G. Stochastic pairing of heavy-chain and κ light-chain variable gene families in polyclonally activated B cells. Proc Natl Acad Sci USA 1990, 87:4932-4936.
84. Sasso E.H., Buckner J.H., Suzuki L.A. Ethnic differences of polymorphism of an immunoglobulin VH3 gene. J Clin Invest 1995, 96:1591-1600.
85. Cook G.P., Tomilson I.M. The human immunoglobulin VH repertoire. Immunol Today 1995, 16:237-242.
86. Yang P.M., Olsen N.J., Siminovitch K.A., Olee T., Kozin F., Carson D.A., Chen P.P. Possible deletion of developmental regulated heavy-chain variable region gene in autoimmune diseases. Proc Natl Acad Sci USA 1990, 87:7907-7911.
87. Mo L., Liu S.J., Barry C., Liu F., Olee T., Yang X.Y., Beardsley D.S., McMillan R., Woods V.L. The frequency of homologous deletetion of a developmentally regulated VH gene (Hunhv3005) is increased in patients with chronic idiopathic thrombocytemia purpura. Autoimmunity 1996, 24:257-263.
88. Adderson E.E., Shackelford P.G., Quinn A., Wilson P.M., Cunningham M.W., Insel R.A., Caroll W.L. Restricted immunoglobulin VH usage and VDJ combination in the human response to Haemophilus influenzae type b capsular polysaccharide. Nucleotide sequences of monospecific anti-Haemophilus antibodies and polyspecific antibodies cross-reacting with self-antigens. J Clin Invest 1993, 91:2734-4387.
89. Chan C.H., Hadlock K.G., Foung S.K., Levy S. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 2001, 97:1023-1026.
90. Knight G., Agnello V. WA monoclonal rheumatoid factors and non-Hodgkin's lymphoma. Blood 2001, 97:3319-3321.
91. Kipps T.J. Chronic lymphocytic leukemia. Curr Opin Hematol 2000, 7(4):223-234.
92. Stevenson F.K., Longhurst C., Chapman C.J., Ehrenstein M., Spellberger M.B., Hamblin T.J., Ravirajan C.T., Latchman D., Isenberg D. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus. J Autoimmunity 1993, 6:809-825.
93. Sasso E.H., Willems van Dijk K., Bull A.P., Milner E.C. A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles. J Clin Invest 1993, 91:2358-2367.
94. Sasso E.H., Johnson T., Kipps T.J. Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number. J Clin Invest 1996, 97:2074-2080.
95. Vencovsky J., Zdarsky E., Moyes S.P., Hajeer A., Ruzickova S., Cimburek Z., Ollier W.E., Maini R.N., Mageed R.A. Polymorphism in the immunoglobulin VH gene V1-69 affects susceptibility to rheumatoid arthritis in subjects lacking the HLA-DRB1 shared epitope. Rheumatology 2002, 41:401-410.
96. Brezinschek H.P., Brezinschek R.I., Lispky P.E. Analysis of the heavy chain repertoire of human peripheral B cells using single cell polymerase chain reaction. J Immunol 1995, 155:190-202.
97. Brezinschek H.P., Foster S.J., Brezinschek R.I., Dorner T., Domiati-Saad R., Lipsky P.E. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM +B cells. J Clin Invest 1997, 99:2488-2501.
98. Dorner T., Brezinschek H.P., Brezinschek R.I., Foster S.J., Domiati-Saad R., Lipsky P.E. Analysis of the frequency and pattern of somatic mutations within non-productively rearranged human variable heavy chain genes. J Immunol 1997, 158:2779-2789.
99. Betz A.G., Neuberger M.S., Milstein C. Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. Immunol Today 1993, 14:405-411.
100. Lossos I.S., Tibshirani R., Levy R. Narasimhan^B. J Immunol 2000, 165:5122-5126.
101. Roelcke D. Cold agglutination. Transfus Med Rev 1989, 3:140-146.
102. Pascual V., Victor K., Lesz D., Spellerberg M.B., Hamblin T.J., Thompson K.M., Randen I., Natvig J., Capra D.J., Stevenson F.K. Nucleotide sequence analysis of the V regions of two IgM cold agglutinin. Evidence that VH4-21 gene segment is responsible for the major crossreactive idiotype. J Immunol 1991, 146:4385-4391.
103. Silberstein L.E., Jefferies L.C., Goldman J., Friedman D., Moore J.S., Nowell P.C., Roelcke D., Pruzanski W., Roudier J., Silverman G.J. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 1991, 78:2372-2386.
104. Li Y., Spellerberg M.B., Stevenson F.K., Capra J.D., Potter K.N. The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies in determined by both VH framework region 1 and complementarity determining region 3. J Mol Biol 1996, 25:577-589.
105. Li H., Llera A., Malchiodi E.L., Mariuzza R.A. The structural basis of T cell activation by superantigens. Annu Rev Immunol 1999, 17:435-466.
106. Potter K.N., Hobby P., Klijn S., Stevenson F.K., Sutton B.J. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell antigen. J Immunol 2002, 169:3777-3782.
107. Cauerhff A., Braden B.C., Carvalho J.G., Aparicio R., Polikarpov I., Leoni J., Goldbaum F.A. Three-dimensional structure of the Fab from a human IgM cold agglutinin. J Immunol 2000, 165:6422-6428.
108. Nashed E.M., Glaudemans C.P. Observations on the binding of four anti-carbohydrate monoclonal antibodies to their homologous ligands. J Biol Chem 1996, 271:8209-8214.
109. Spellerberg M.B., chapman C.J., Mockridge C.I., Isenberg D.A., Stevenson F.K. Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene: A possible link between infection and lupus. Hum Antibodies Hybridomas 1995, 6:52-56.
110. Stevenson F.K., Longhurst C., Chapman C.J., Ehrenstein M., Spellerberg M.B., Hamblin T.J., Ravirajan C.T., Latchman D., Isenberg D. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus. J Autoimmun 1993, 6:809-825.
111. Silverman G.J. B-cell superantigens. Immunol Today 1997, 18:379-386.
112. Boyle M.D.P. Bacterial immunoglobulin binding proteins 1990, Vol. 1:17-28. Academic Press, San Diego. M.D.P. Boyle (Ed.).
113. Patel A.H., Nowlan P., Weavers E.D., Foster T. Viruslence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun 1987, 55:103-110.
114. Potter K.N., Li Y., Capra J.D. Staphylococcal protein A simultaneously interacts with framework region 1, complementarity determining region 2 and framework region 3 on human VH3-encoded Igs. J Immunol 1996, 157:2982-2988.
115. Graille M., Stura E.A., Corper A.L., Sutton B.J., Taussig M.J., Charbonnier J.B., Silverman G.J. Crystal structure of a Staphylococcus aureus protein a domain complexed with the Fab fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci USA 2000, 97:5399-5404.
116. Kirkham P.M., Schroeder H.W. Antibody structure and the evolution of immunoglobulin V gene segments. Semin Immunol 1994, 6:347-360.
117. Goodglick L., Zevit N., Neshat M.S., Braun J. Mapping the Ig superantigen-binding site of HIV-1 gp120. J Immunol 1995, 155:5151-5159.
118. Bye J.M., Carter C., Cui Y., Gorick B.D., Songsivilai S., Winter G., Hughes-Jones N.C., Marks J.D. Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift. J Clin Invest 1992, 90:2481-2490.
119. Thorpe S.J., Turner C.E., Stevenson F.K., Spellerberg M.B., Thorpe R., Natvig J.B., Thompson K.M. Human monoclonal antibodies encoded by the V4-34 gene segment show cold agglutinin activity and variable multireactivity which correlates with the predicted charge of the chain variable region. Immunology 1998, 93:129-136.
120. Sutton B., Corper A., Bonagura V., Taussig M. The structure and origin of rheumatoid factors. Immunol Today 2000, 21:177-183.
121. Feizi T. Monotypic cold agglutinins in infection by Mycoplasma pneumoniae. Nature 1967, 215:540-542.
122. Chapman C.J., Spellerberg M.B., Smith G.A., Carter S.J., Hamblin T.J., Stevenson F.K. Autoanti-red cell antibodies synthesized by patients with infectious mononucleosis utilize the VH4-21 gene segment. J Immunol 1993, 151:1051-1061.
123. Stevenson F.K., Smith G.J., North J., Hamblin T.J., Glennie M.J. Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anti-I and anti-i specificity. Br J Haematol 1989, 72:1-15.
124. Isenberg D., Spellerberg M.B., Williams W., Griffiths M., Stevenson F.K. Identification of the 9G4 idiotope in systemic lupus erythematosus. Br J Rheum 1993, 32:876-882.
125. Isenberg D.A., McClure C., Farewell V., Spellerberg M., Williams W., Cambridge G., Stevenson F.K. Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 1998, 57:566-570.
126. Thomas M.D., Clough K., Melamed M.D., Stevenson F.K., Chapman C.J., Spellerberg M.B., Potter K.N., Newton-Bishop J.A. A human monoclonal antibody encoded by the V-4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1. Hum Antibodies 1999, 9:95-106.
127. Bhat N.M., Bieber M.M., Hsu F.J., Chapman C.J., Spellerberg M., Stevenson F.K., Teng N.N. Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies, II. Clin Exp Immunol 1997, 108:51-59.
128. Baum H., Berg P.A. The complex nature of mitochondrial antibodies and their relation to primary biliary cirrhosis. Semin Liver Dis 1981, 1:309-321.
129. Coppel R.L., Gershwin M.E. Primary biliary cirrhosis: The molecule and the mimic. Immunol Rev 1995, 144:17-49.
130. Matsui M., Nakamura M., Ishibashi H., Koike K., Kudo J., Niho Y. Human monoclonal antibodies from a patient with primary biliary cirrhosis that recognize two distinct autoepitopes in the E2 component of the pyruvate dehyrogenase complex. Hepatology 1993, 18:1069-1077.
131. Thomson R.K., Davis Z., Palmer J.M., Arthur M.J., Yeaman S.J., Chapman C.J., Spellerberg M.B., Stevenson F.K. Immunogenetic analysis of a panel of monoclonal IgG and IgM anti-PDC-E2/X antibodies derived from patients with primary biliary cirrhosis. J Hepatol 1998, 28:582-594.
132. Potter K.N., Thomson R.K., Hamblin A., Richards S.D., Lindsay J.G., Stevenson F.K. Immunogenetic analysis reveals that epitope shifting occurs during B-cell affinity maturation in primary biliary cirrhosis. J Mol Biol 2001, 306:37-46.
133. Adams D.D., Fastier F.N., Howie J.B., Kennedy T.H., Kilpatrick J.A., Stewart R.D. Stimulation of the human thyroid by infusions of plasma containing LATS protector. J Clin Endocr Metab 1974, 39:826-832.
134. Seetharamaiah G.S., Wagle N.M., Morris J.C., Prabhakar B.S. Generation and characterization of monoclonal anti-bodies to block thyrotropin receptor. Endocrinology 1995, 136:2817-2824.
135. Zakarija M. The thyroid-stimulating antibody of Graves' disease: Evidence for restricted heterogeneity. Horm Res 1980, 13:1-15.
136. Pepper B., Noel E.P., Farid N.R. The putative antithropin receptor antibodies of Graves' disease. I.GM allotypes. Immunogenetics 1981, 8:89-100.
137. Shin E.K., Akamizu T., Matsuda F., Sugawa H., Fijikura J., Mori T., Honjo T. Variable regions of Ig heavy chain genes encoding anti-thyrotropin antibodies of patients with Graves' disease. J Immunol 1994, 152:1485-1492.
138. Akamizu T., Matsuda F., Okuda J., Li H., Kanda H., Watanabe T., Honjo T., Mori T. Molecular analysis of stimulatory antithropin receptor antibodies involved in Graves' disease. J Immunol 1996, 157:3148-3152.
139. Harrington W.J., Sprague C.C., Minich V., Carl C.V., Moore R.C., Aulvin R.C., Dubach R. Immnologic mechanisms in neonatal thrombocytopenic purpura. Ann Intern Med 1953, 38:433-469.
140. Van Leeuwen E.F., van der Ven J.T.M., Engelfriet C.P., von dem Borne A.E. Specificity of autoantibodies in autoimmune thrombocytopenia. Blood 1982, 59:23-26.
141. Fujisawa K., O'Toole T.E., Tani D., Loftus J.C., Plow E.F., Ginsberg M.H., McMillian R. Autoantibodies to presumptive cytoplasmic domain of platelet glycoprotein IIIa in patients with chronic immune thrombocytopenic purpura. Blood 1991, 77:2207-2213.
142. Kunichi T.J., Plow E.F., Kekomaki R. Human monoclonal antibody 2E7 is specific for a peptide sequence of platelet glycoprotein IIb. J Autoimmun 1991, 4:415-431.
143. Nugent D.J., Kijiniki T.J., Berglund C., Bernstein I.D. A human monoclonal antibody recognizes a neoantigen on glycoprotein nIa expressed on stored and activated platelets. Blood 1987, 70:16-22.
144. Kinicki T.J., Annis D.S., Gorski J., Nugent D.J. Nucleotide sequence of human autoantibody 2E7 specific for platelet integrin IIb heavy chain. J Autoimmun 1991, 4:422-446.
145. Deckmin H., Zhang J., Van Houtte E., Vermylen J. Production and nucleotide sequence of an inhibitory directed against platelet glycoprotein Ia/IIa. Blood 1994, 84:1968-1974.
146. Olee T., En J., Lai C.J., Mo L., Cho C.S., Wei X., Wang X.E., Woods V.L., Chen P. Generation and analysis of an IgG anti-platelet autoantibody reveals unususal molecular features. Br J Haematol 1997, 96:836-845.
147. Nugent D.J. Human monoclonal antibodies in the characterization of platelet antigens. Platelet immunobiology: Molecular and clinical aspects 1989, 273-290. Lippincott, Philadelphia. T.J. Kunicki, J.N. George (Eds.).
148. Hiraiwa A., Nugent D.J., Milner E.C.B. Sequence analysis of monoclonal antibodeies derived from a patient with idiopathic purpura. Autoimmunity 1990, 8:107-113.
149. Griffin H.M., Ouwehand W.H. A human monoclonal antibody specific for the leucine-33 from protein of platelet glycoprotein IIa from a V gene phage display library. Blood 1955, 86:4430-4436.
150. Okamoto N., Kennedy S.D., Barron-Casella E.A., Inoko H., Kickler T.S. Identification of a human heavy chain antibody display library. Tissue Antigens 1998, 51:156-163.
151. Proulx C., Chartrand P., Roy V., Goldman M., Decary F., Rinfert A. Human monoclonal Fab fragments recovered from a combinatorial library bind specifically to the platelet HPA-1a alloantigen on glycoprotein IIb-IIIa. Vox Sangiunis 1997, 75:52-60.
152. Jacobin M.-J., Laroch-Traineau J., Little M., Keller A., Peter K., Nurden A., Clofen-Sanchez G. Human IgG monoclonal anti aIIb-b3 binding fragments derived from immunized donors using phage display library. J Immunol 2002, 168:2035-2045.
153. Sims G.P., Shino H., Wilcox N., Stott D.I. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J Immunol 2001, 167:1935-1944.
154. Marx A. Myasthenia gravis. The molecular pathology of autoimmune diseases 2001, 752-776. Taylor and Francis, New York, London. A.N. theofilopoulos, C.A. Bona (Eds.).
155. Wang H.B., Li, He B., Bakheit M., Levi M., Wahren B., Berglof A., Sandstedt K. The role of B cells in experimental myasthenia gravis in mice. Biomed Pharmacother 1999, 53:227-233.
156. Gardenerova M., Eymard B., Morel E., Faltin M., Zjac J., Sadovsky O., Tripon P., Domergue M., Vernet-der Garabedian B., Bach J.F. The fetal/adult acetylcholine antibody ratio into mothers with myastenia gravis as marker for transfer of disease to the newborn. Neurology 1997, 48:50-54.
157. Vincent A., Newland C., Brueton L., Beeson D., Riemersma S., Huson S.M., Newsom-Davis J. Arthrogryposis multiplex congenita with maternal autoantibodies specific for fetal antigen. Lancet 1995, 346:24-25.
158. Engle A.G., Lambert E.H., Howard F.M. Immune complexes at the motor end plates: A structural and light microscopic localization. Clin Immunol 1997, 52:267-280.
159. Mamalaki A., Tzartos S.J. Nicotinic acetylcholine receptor: Structure, function and main immunogenic region. Adv Neuroimmunol 1994, 4:339-354.
160. Vincent A., Newsom-Davis J. Acetylcholine antibody characteristics in myastenia gravis. I Patients with generalized myasthenia or disease restricted to ocular muscle. Clin Exp Immunol 1982, 49:257-265.
161. Heidenreich F., Jovin T. Synthesis of anti-acetylcholine receptor antibodies by CD5-B cells from peripheral blood of myasthenia gravis patients. J Neurol 1996, 243:57-62.
162. Guigou V., Emillie D., Berrih-Aknin S., Fumoux F., Fougereau M., Schiff C. Individual germinal centers of myasthenia gravis human thymuses contain polyclonal activated B cells that express all Vh and Vk families. Clin Exp Immunol 1991, 83:262-266.
163. Victor K.D., Pascual V., Lefvert A.-K., Capra J.D. Human anti-acetylcholine receptor antibodies use variable gene segments analogous to those used in autoantibodies of various specificities. Mol Immunol 1992, 29:1501-1506.
164. Serrano M.P., Cardona A., Vernet der Garabedian B., Bach J.-F., Pleau J.-M. Nucleotide sequences of variable regions of an human anti-acetylcholine receptor autoantibody derived from a myasthenic patient. Mol Immunol 1994, 31:413-417.
165. Farrar J., Portolano S., Wilcox N., Vincent A., Jacobson L., Newsom-Davis J., Rappaport B., McLachlan S.M. Diverse Fab specific acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library. Int Immunol 1997, 9:1311-1318.
166. Graus Y.F., de Baets M.H., Parren P.W.H.I., Berrih-Akinin S., Wokke J., van Breda Vriesman P.J., Burton D.R. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated fro thymus derived display library from myasthenia gravis patients. J Immunol 1997, 158:1919-1929.
167. Graus Y.M.F., Verschuuren J.J.G.M., Bos N.A., van Breda Vriesman P.J.C., De Baets M.H. Vh gene family utilization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthena gravis. J Neurimmunol 1993, 43:113-124.
168. Graus Y., Meng F., Vincent A., van Breda Vriesman P., De Baets M. Sequence analysis of anti-AchR antibodies in experimental autoimmune myasthenia gravis. J Immunol 1995, 154:6382-6396.
169. McCuistion C.H., Schoch E.P. Possible discoid lupus erythematosus in newborn infant. Arch Dermatol 1954, 70:782-785.
170. Campos S., Campos-Carvalho A.C. Neonatal lupus syndrome: The heart as a target of immune system. An Acad Bras Cienc 2000, 72:83-89.
171. Lee L.A. Neonatal lupus erythematosus. J Invest Dermatol 1993, 100:9S-13S.
172. Hull D., Binns B., Joyce D. Congenital heart block and widespread fibrosis due to maternal lupus erythematosus. Arch Dis Child 1966, 41:688-690.
173. Buyon J.P., Slade S.G., Reveille J.D., Hamel J.C., Chan E.K.L. Autoantibody response to the native 52-kDA SSA/Ro protein in neonatal lupus syndrome, systemic lupus erythematosus, and Sjogren' syndrome. J Immunol 1994, 152:3675-3684.
174. Suzuki H., Takemura H., Suzuki M., Sekine Y., Kashiwagi H. Molecular cloning of anti-SS-A/Ro 60kDa peptide fragments from infiltrating salivary gland infiltration of a patients with Sjogren's syndrome. Biochem Biophys Res Comm. 1997, 232:101-106.
175. Elagib K.E. Immunoglobulin variable genes and epitope recognition of human monoclonal anti-ro 52 kd in primary Sjogren's syndrome. Arthritis Rheum 1999, 42:2471-2481.
176. Tsokos G.C., Boumpas D. Human systemic lupus erythematosus. The molecular pathology of autoimmune diseases 2002, 261-288. Taylor and Francis, New York, London. A. Theophilopoulos, C. Bona (Eds.).
177. Eibling F., Hahn B. Restricted population of DNA antibodies in kidney of mice with systemic lupus. Comparison of antibodies in serum and renal eluates. Arthritis Rheum 1980, 23:392-403.
178. Ebling F.M., Hahn B. Pathogenic subset of antibodies to DNA. Int Rev Immunol 1989, 5:79-95.
179. Suzuki N., Harada T., Mizushima Y., Sakane T. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. J Immunol 1993, 141:1128-1136.
180. Liveh A., Halpern A., Perkins D., Lazo A., Halperm R., Dimond B. A monoclonal antibody to a crossreactive idiotype on cationic human anti-DNA antibodies. J Immunol 1987, 138:123-127.
181. Winkler T.H., Fehr H., Kalden J.R. Analysis of immunoglobulin variable region genes from human anti-IgG anti-DNA hybridomas. Eur J Immunol 1992, 22:1719-1728.
182. Ravirajan C.T., Rahman M.A., Papdaki L., Griffith M.H., Kalsi J., Martin A.C., Ehrenstein M.R., Latchman D.S., Isnberg D.A. Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis. Eur J Immunol 1988, 28:339-350.
183. Van Es J.H., Gmelig F.H.J., van de Akler W.R.M., Ansfort H., Derksen R.H.W.M., Logtenberg T. Somatic mutation in the variable regions of a human anti-double strand DNA antibody. J Exp Med 1991, 173:461-470.
184. Grammer A.C., Dorner T., Lipsky P.E. Abnormalities in B cell activity and the immunoglobulin repertoires in human systemic lupus erythematosus. The molecular pathology of autoimmune diseases 2002, 288-324. Taylor and Francis, New York, London. A.N. Theofilopoulos, C.A. Bona (Eds.).
185. Roben P., Barbas S.M., Sandoval L., Lecerf J.M., Stollar B.D., Solomon A., Silverman G.J. Repertoire cloning of anti-DNA antibodies. J Clin Invest. 1996, 98:2827-2837.
186. Radic M.Z., Weigert M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 1994, 12:487-520.
187. Mockridge C.I., Chapman C.J., Spellberg M.B., Isenberg D.A., Stevenson F.K. Use of phage surface expression to analyze regions of a human V4-34(vh4-21)-encoded IgG auto-antibody required for recognition of DNA. J Immunol 1996, 157:2449-2454.
188. Krishnan M.R., Jou N.-T., Marion T.N. Correlation between the aminoacid position of arginine in VH0CDR3 and specificity for native DNA among autoimmune antibodies. J Immunol 1996, 157:2430-2439.
189. Barbas S.M., Ditzel H., Salonen E.M., Yang W.-P., Silverman G.J., Burton D.R. Human autoantibody recognition of DNA. Proc Natl Acad Sci USA 1995, 2:2529-2533.
190. Rahman A., Menon S., Latchman D.S., Insberg D.A. Sequence of monoclonal antiphospholipid antibodies on an anti-DNA antibody theme. Semin Arthritis Rheum 1996, 26:515-525.
191. Harris E.N., Gharavi A.E., Boey M.L., Patel B.M., Mackworth-Young C.G., Loizu S., Huges G.R. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erthymatosus patients. Lancet 1983, 2:1211-1214.
192. Aron A.L., Cuelalar M.L., Brey R.L., Mackeovan S., Espinoza L.R., Shoenfeld Y., Gharavi A.E. Clin Exp Immunol 1995, 101:78-81.
193. Branch D.W., Dudely D.J., Mitchell K.A., Creighton T.M., Abbott E.H., Hammond E.H., Haynes R.A. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in Balb/c mice: A model for autoimmune fetal loss. Am J Obstet Gynecol 1990, 163:1410-1415.
194. Pierangelli S.S., Harris E.N. Antiphospholipid antibodies an in vivo thrombosis model in mice. Lupus 1994, 3:247-251.
195. Olee T., Pierangelli S.S., Handely H.H., Le D.T., Wei X., Lai C.J., En J., Nowotny W., Harris E.N., Woods V.L.J., Chen P.P. A monoclonal IgG anticariolipin antibody from a patient with antiphospholipid syndrome is thrombogenic in mouse. Proc Natl Acad Sci USA 1996, 93:8606-8611.
196. Reddle S.W., Kirilis S.A. The anti-phospholipid syndrome. The molecular pathology of autoimmune diseases 2002, 325-352. Taylor and Francis, New York, London. A. Theophilopoulos, C. Bona (Eds.).
197. Logtenberg T., Young F.M., Vanes J.H. Autoantibodeis encoded by the most Jh-proximal human immunoglobulin heavy chain region gene. J Exp Med 1989, 170:1347-1355.
198. Harmer I.J., Loizu S., Thompson K.M., So K.M., Walport A.K.L., Macgrowth-Young C. A human monoclonal antiphospholipid antibody that is representative of serum antibodies and is germline encoded. Arhritis Rheum 1995, 38:1068-1076.
199. Chukwuocha R.U., Hsiao E.T., Shaw P., Wiztum J.L., Chen P.P. Isolation, characterization, and sequence analysis of five Igg anti-b2-glycoprotein1 and anti-prothrombin antigen-binding fragments generated by phage display. J Immunol 1999, 163:4606-4611.
200. Siminovitvh K.A., Misener V., Kwong P.K., Yang P.-M., Laskin C.A., Cairns E., Bell D., Rubin L.A., Chen P.P. A human anti-cardioipin autoantibody is encoded by developmentally restricted heavy and light chain variable region genes. Autoimmunity 1990, 8:97-105.
201. Hohmann A., Cairns E., Brisco M., Bell D.A., Dimond B. Immunoglobulin gene sequence analysis of anti-cardiolipin and anti-cardiolipin idiotype (H3) human monoclonal antibodies. Autoimmunity 1995, 22:49-58.
202. Chukwoka R.U., Zhu M., Cho C.S., Vivanathan S., Hwang K.K., Rahman A., Chen P.P. Molecular and genetic characterization of five pathogenic and two non-pathogenic monoclonal anti-phospholipid antibodies. Mol Immunol 2002, 39:299-311.